Ondansetron Injection
Product Images NDC 23155-549

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 23155-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron Spl 20ml Carton Label

Packaging label for Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) multi-dose vial. The injection is for intravenous or intramuscular use. Labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label includes storage instructions and ingredient information, stating it is sterile and nonpyrogenic. Manufactured for Avet Pharmaceuticals Inc. and Gland Pharma Limited. The label features the NDC 23155-549-31 and a barcode.*

FDA Label Image

Ondansetron Spl 20ml Vial Label

Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) multi-dose vial label indicating intramuscular and intravenous use. The label includes the NDC 23155-549-31, manufacturer information as Avet Pharmaceuticals Inc., and storage instructions. The vial size is 20 mL and it displays barcode and lot/expiration placeholders.*

FDA Label Image

Ondansetron Spl 2ml Carton Label

Packaging label for Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL) single-dose vials, 25 x 2 mL vials per carton. The label shows the product is for intravenous or intramuscular injection and is manufactured for Avet Pharmaceuticals Inc. The label includes storage instructions, contents per mL, and a partition design graphic for packing 25 vials.*

FDA Label Image

Ondansetron Spl 2ml Vial Label

Label for Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) single-dose vial for intravenous or intramuscular injection. The label includes NDC 23155-547-31 and indicates the product is preservative-free and nonpyrogenic. Manufactured by Avet Pharmaceuticals Inc., Brunswick, NJ, with production in India. The label shows barcodes and batch information placeholders.*

FDA Label Image

Ondansetron Structure

Chemical structure of ondansetron hydrochloride dihydrate, showing the molecular arrangement of rings and functional groups including a methyl-substituted indole and imidazole ring system with a hydrochloride and two water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.